2020 ASCO Virtual Direct™ Highlights
Breast
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on De-Escalation in Early Stage HER2+ BC: Should All Patients Receive Neoadjuvant Chemotherapy Just Because They Have HER2+ Disease? Can 6 vs. 12 Months of Anti-HER2 Therapy Be Equally Effective?
FEATURING
Alvaro Moreno-Aspitia
- 246 views
- August 26, 2020